Efficacy and Safety of NNC 0078-0000-0007 in Patients With Congenital Haemophilia and Inhibitors

Clinical trial NCT01392547 · COMPLETED

Trial details

NCT number: NCT01392547
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Congenital Bleeding Disorder Haemophilia A With Inhibitors Haemophilia B With Inhibitors

Start date: 2011-07-01
Primary completion: 2012-08-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.